Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Santander – page 50

611 clinical trials in Santander, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Santander at a glance
611
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

611 trials in Santander

Open in trial search

Study on Letermovir for Preventing CMV Infection in Lung Transplant Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Letermovir
  • Sponsor:Fundacion Para La Investigacion Biomedica De Cordoba

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Kite Pharma Inc.

Psoriasis

Not recruiting

Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Sponsor:Amgen Inc.

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Study Comparing Standard Chemotherapy with Letrozole and Abemaciclib for High/Intermediate Risk HR-Positive, HER2-Negative Breast Cancer Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Study of Olaparib and Durvalumab for Patients with Metastatic Pancreatic Cancer and DNA Repair Gene Alterations

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Asociacion Grupo Tratamiento De Tumores Digestivos

Plasma cell myeloma

Not recruiting

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:European Myeloma Network B.V.

Plasma cell myeloma

Not recruiting

Study of Belantamab Mafodotin, Carfilzomib, and Dexamethasone for Patients with Relapsed Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Fundacion PETHEMA

Liver disorder

Not recruiting

Study on Zinc Acexamate for Patients with Advanced Chronic Liver Disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zinc Acexamate
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Santander

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on metastatic colorectal cancer, mantle cell lymphoma, and gastrointestinal cancers. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.

  • Colorectal Cancer Treatment Innovations
  • Lymphoma Therapy Advances
  • Gastric Cancer Interventions

Multiple studies exploring new therapeutic approaches for various cancer types, including melanoma and lung cancer.

02 Respiratory Medicine

Clinical trials investigating treatments for chronic rhinosinusitis and uncontrolled asthma. Research focuses on developing innovative therapies and improving patient quality of life.

  • Asthma Management
  • Nasal Polyps Treatment
  • Respiratory Disease Control

Studies evaluate both established and novel therapeutic approaches for respiratory conditions.

03 Autoimmune Disorders

Innovative research examining treatments for psoriatic arthritis and Sjögren's disease. Trials focus on evaluating new biological therapies and their effectiveness in managing symptoms.

  • Arthritis Treatment Solutions
  • Autoimmune Disease Management
  • Biological Therapy Assessment

Comprehensive studies targeting various manifestations of autoimmune conditions.

04 Neurological Studies

Research investigating treatments for Alzheimer's disease and its connection with Down syndrome. Studies also include trials for multiple sclerosis and related neurological conditions.

  • Alzheimer's Disease Research
  • Multiple Sclerosis Treatments
  • Neurological Disease Management

Focused on developing effective treatments for complex neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.